These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 17922867)

  • 21. Fructose transporter GLUT5 expression in clear renal cell carcinoma.
    Medina Villaamil V; Aparicio Gallego G; Valbuena Rubira L; García Campelo R; Valladares-Ayerbes M; Grande Pulido E; Victoria Bolós M; Santamarina Caínzos I; Antón Aparicio LM
    Oncol Rep; 2011 Feb; 25(2):315-23. PubMed ID: 21165569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential expression of facilitative glucose transporters in normal and tumour kidney tissues.
    Suganuma N; Segade F; Matsuzu K; Bowden DW
    BJU Int; 2007 May; 99(5):1143-9. PubMed ID: 17437443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypoxic status in ovarian serous and mucinous tumors: relationship between histological characteristics and HIF-1alpha/GLUT-1 expression.
    Iida T; Yasuda M; Miyazawa M; Fujita M; Osamura RY; Hirasawa T; Muramatsu T; Murakami M; Saito K; Mikami M
    Arch Gynecol Obstet; 2008 Jun; 277(6):539-46. PubMed ID: 18026974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential expression of the enzyme that esterifies retinol, lecithin:retinol acyltransferase, in subtypes of human renal cancer and normal kidney.
    Zhan HC; Gudas LJ; Bok D; Rando R; Nanus DM; Tickoo SK
    Clin Cancer Res; 2003 Oct; 9(13):4897-905. PubMed ID: 14581364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidermal growth factor receptor and transforming growth factor alpha expression in papillary and nonpapillary renal cell carcinoma: correlation with metastatic behavior and prognosis.
    Uhlman DL; Nguyen P; Manivel JC; Zhang G; Hagen K; Fraley E; Aeppli D; Niehans GA
    Clin Cancer Res; 1995 Aug; 1(8):913-20. PubMed ID: 9816062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Different vascular endothelial growth factor (VEGF), VEGF-receptor 1 and -2 mRNA expression profiles between clear cell and papillary renal cell carcinoma.
    Ljungberg BJ; Jacobsen J; Rudolfsson SH; Lindh G; Grankvist K; Rasmuson T
    BJU Int; 2006 Sep; 98(3):661-7. PubMed ID: 16925769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemical expression of hypoxia inducible factor-1alpha and its downstream molecules in sarcomatoid renal cell carcinoma.
    Tickoo SK; Alden D; Olgac S; Fine SW; Russo P; Kondagunta GV; Motzer RJ; Reuter VE
    J Urol; 2007 Apr; 177(4):1258-63. PubMed ID: 17382701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of tenascin-C expression in clear cell renal cell carcinoma.
    Ohno Y; Izumi M; Yoshioka K; Ohori M; Yonou H; Tachibana M
    Oncol Rep; 2008 Sep; 20(3):511-6. PubMed ID: 18695899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of stanniocalcin 2 as prognostic marker in renal cell carcinoma.
    Meyer HA; Tölle A; Jung M; Fritzsche FR; Haendler B; Kristiansen I; Gaspert A; Johannsen M; Jung K; Kristiansen G
    Eur Urol; 2009 Mar; 55(3):669-78. PubMed ID: 18450365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anillin expression is a marker of favourable prognosis in patients with renal cell carcinoma.
    Ronkainen H; Hirvikoski P; Kauppila S; Vaarala MH
    Oncol Rep; 2011 Jan; 25(1):129-33. PubMed ID: 21109967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Membranous expression and prognostic implications of epidermal growth factor receptor protein in human renal cell cancer.
    Merseburger AS; Hennenlotter J; Simon P; Kruck S; Koch E; Horstmann M; Kuehs U; Küfer R; Stenzl A; Kuczyk MA
    Anticancer Res; 2005; 25(3B):1901-7. PubMed ID: 16158924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Significance of Fas expression alteration during tumor progression of renal cell carcinoma.
    Sejima T; Miyagawa I
    Int J Urol; 2006 Mar; 13(3):257-64. PubMed ID: 16643620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biologic significance of fascin expression in clear cell renal cell carcinoma: systematic analysis of primary and metastatic tumor tissues using a tissue microarray technique.
    Zigeuner R; Droschl N; Tauber V; Rehak P; Langner C
    Urology; 2006 Sep; 68(3):518-22. PubMed ID: 16979727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The lymphatic system and its specific growth factor vascular endothelial growth factor C in kidney tissue and in renal cell carcinoma.
    Voss M; Steidler A; Grobholz R; Weiss C; Alken P; Michel MS; Trojan L
    BJU Int; 2009 Jul; 104(1):94-9. PubMed ID: 19500329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The expression and significance of HIF-1alpha and GLUT-3 in glioma.
    Liu Y; Li YM; Tian RF; Liu WP; Fei Z; Long QF; Wang XA; Zhang X
    Brain Res; 2009 Dec; 1304():149-54. PubMed ID: 19782666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of hypoxia-inducible factor-1 alpha and its prognostic significance in small-sized adenocarcinomas of the lung.
    Enatsu S; Iwasaki A; Shirakusa T; Hamasaki M; Nabeshima K; Iwasaki H; Kuroki M; Kuroki M
    Eur J Cardiothorac Surg; 2006 Jun; 29(6):891-5. PubMed ID: 16675263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The expression of prostate stem cell antigen in human clear cell renal cell carcinoma: a quantitative reverse transcriptase-polymerase chain reaction analysis.
    Elsamman EM; Fukumori T; Tanimoto S; Nakanishi R; Takahashi M; Toida K; Kanayama HO
    BJU Int; 2006 Sep; 98(3):668-73. PubMed ID: 16925770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of hypoxia-inducible factor-1alpha predicts an unfavorable outcome in urothelial carcinoma of the upper urinary tract.
    Ke HL; Wei YC; Yang SF; Li CC; Wu DC; Huang CH; Wu WJ
    Int J Urol; 2008 Mar; 15(3):200-5. PubMed ID: 18304212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Global histone H3 lysine 27 (H3K27) methylation levels and their prognostic relevance in renal cell carcinoma.
    Rogenhofer S; Kahl P; Mertens C; Hauser S; Hartmann W; Büttner R; Müller SC; von Ruecker A; Ellinger J
    BJU Int; 2012 Feb; 109(3):459-65. PubMed ID: 21810159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Expression of hypoxia inducible factor-1α and correlated target genes in human laryngeal carcinoma].
    XU O; LI XM; WANG MX; QU YT; LU XY; SHAN CG; SUN QJ
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Apr; 47(4):330-3. PubMed ID: 22800355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.